Tower Research Capital (TRC)’s China Biologic Products Holdings, Inc. CBPO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q2 | – | Sell |
-177
| Closed | -$21K | – | 6347 |
|
|
2021
Q1 | $21K | Sell |
177
-1,012
| -85% | -$120K | ﹤0.01% | 3864 |
|
|
2020
Q4 | $140K | Buy |
1,189
+1,074
| +934% | +$125K | ﹤0.01% | 2045 |
|
|
2020
Q3 | $13K | Sell |
115
-792
| -87% | -$85K | ﹤0.01% | 4013 |
|
|
2020
Q2 | $93K | Buy |
907
+899
| +11,238% | +$96.2K | ﹤0.01% | 2524 |
|
|
2020
Q1 | $1K | Buy |
+8
| New | +$919 | ﹤0.01% | 2940 |
|
|
2019
Q4 | – | Sell |
-215
| Closed | -$25K | – | 4895 |
|
|
2019
Q3 | $25K | Sell |
215
-1,546
| -88% | -$154K | ﹤0.01% | 2328 |
|
|
2019
Q2 | $168K | Buy |
1,761
+1,439
| +447% | +$136K | 0.01% | 933 |
|
|
2019
Q1 | $30K | Sell |
322
-1,162
| -78% | -$95.1K | ﹤0.01% | 2058 |
|
|
2018
Q4 | $112K | Buy |
1,484
+1,260
| +563% | +$92.7K | 0.01% | 915 |
|
|
2018
Q3 | $18K | Buy |
224
+57
| +34% | +$5.31K | ﹤0.01% | 2435 |
|
|
2018
Q2 | $16K | Sell |
167
-571
| -77% | -$49.3K | ﹤0.01% | 2571 |
|
|
2018
Q1 | $59K | Buy |
738
+407
| +123% | +$32.9K | 0.01% | 1595 |
|
|
2017
Q4 | $26K | Buy |
+331
| New | +$27.5K | ﹤0.01% | 1869 |
|
|
2017
Q3 | – | Sell |
-39
| Closed | -$4K | – | 4443 |
|
|
2017
Q2 | $4K | Buy |
+39
| New | +$4.36K | ﹤0.01% | 2170 |
|
|
2017
Q1 | – | Sell |
-357
| Closed | -$38K | – | 4517 |
|
|
2016
Q4 | $38K | Sell |
357
-186
| -34% | -$21.7K | ﹤0.01% | 1622 |
|
|
2016
Q3 | $67K | Buy |
543
+443
| +443% | +$52.3K | 0.01% | 993 |
|
|
2016
Q2 | $11K | Buy |
+100
| New | +$11.6K | ﹤0.01% | 2776 |
|
|
2015
Q4 | – | Sell |
-230
| Closed | -$21K | – | 5501 |
|
|
2015
Q3 | $21K | Buy |
+230
| New | +$24.3K | ﹤0.01% | 1707 |
|
|
2015
Q2 | – | Sell |
-55
| Closed | -$5K | – | 5442 |
|
|
2015
Q1 | $5K | Buy |
+55
| New | +$4.11K | ﹤0.01% | 3312 |
|
|
2014
Q3 | – | Sell |
-1,131
| Closed | -$50K | – | 5209 |
|
|
2014
Q2 | $50K | Buy |
1,131
+284
| +34% | +$11.6K | 0.01% | 1306 |
|
|
2014
Q1 | $30K | Sell |
847
-408
| -33% | -$13K | ﹤0.01% | 1515 |
|
|
2013
Q4 | $36K | Sell |
1,255
-31
| -2% | -$899 | 0.01% | 1699 |
|
|
2013
Q3 | $38K | Sell |
1,286
-508
| -28% | -$12.7K | ﹤0.01% | 2172 |
|
|
2013
Q2 | $42K | Buy |
+1,794
| New | +$45.3K | ﹤0.01% | 1081 |
|
Tower Research Capital (TRC)'s CBPO Position: Q2 2021 in Review
Tower Research Capital (TRC) sold out of China Biologic Products Holdings, Inc. (CBPO) in Q2 2021, closing a stake of 177 shares — an estimated $21K sold.
Tower Research Capital (TRC) first reported a position in CBPO in Q2 2013 and held it in 24 quarters. The position peaked at $168K in Q2 2019. 0 funds tracked by Wall St. Rank hold CBPO as of Q2 2021.
- Tower Research Capital (TRC) reported no remaining China Biologic Products Holdings, Inc. position as of Q2 2021 after selling out during the quarter.
- Tower Research Capital (TRC) sold 177 China Biologic Products Holdings, Inc. shares in Q2 2021, an estimated $21K.
- Tower Research Capital (TRC) first reported a position in China Biologic Products Holdings, Inc. in Q2 2013 and held it in 24 quarters.
- Tower Research Capital (TRC)'s China Biologic Products Holdings, Inc. position peaked at $168K in Q2 2019.
- 0 funds tracked by Wall St. Rank held China Biologic Products Holdings, Inc. as of Q2 2021.
Based on Tower Research Capital (TRC)'s 13F filing for Q2 2021, filed 16 Aug 2021.